Pharmafile Logo

News and Press Releases

PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial

Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries Safety and functionality data for the updated Liquid Biopsy System supports continuation of...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 6, 2025

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease

Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target. 18...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development

Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec 14 May 2024 -- Cambridge, UK -- PlaqueTec, a company identifying endotype-specific biomarkers...

Category: Biotechnology, Drug Discovery
Posted: May 14, 2024

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

PlaqueTec closes $8m equity financing

The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support ongoing BIOPATTERN trial and build BIOCARTA database to transform...

Category: Biotechnology, Other, Pharmaceutical
Posted: April 30, 2024

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood

Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN...

Category: Biotechnology
Posted: January 23, 2024

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

PlaqueTec recruits first ten patients in BIOPATTERN trial

Trial to investigate atherosclerotic cardiovascular diseases receives MHRA approval to continue recruitment towards 300-patient target Unique PlaqueTec Liquid Biopsy System will be used to collect blood samples containing biomolecules localising...

Category: Clinical Trials
Posted: November 29, 2023

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT